At 3 a.m., you wake to excruciating pain in your big toe — so intense that even the weight of a bedsheet feels unbearable. That scenario is the textbook introduction to gout, one of the most painful forms of inflammatory arthritis and one of the oldest recognized diseases in medical history. Gout now affects millions of American adults — on the order of nine million or more — a number that has risen steadily over recent decades alongside increasing rates of obesity, diabetes, and kidney disease. The irony of gout is that it is among the best understood and most treatable forms of arthritis — yet it remains poorly managed in a large share of patients. For context on how this condition relates to other health concerns, see our medical conditions guide.
TL;DR
Gout is caused by needle-like uric acid (monosodium urate) crystals depositing in joints, producing sudden, severe flares — classically in the big toe. Flares are treated with anti-inflammatory medicine, but the definitive treatment is long-term urate-lowering therapy (usually allopurinol) taken to a uric acid target. Diet and lifestyle help but do not replace prescribed medication when it is indicated, and you should not stop urate-lowering therapy on your own. Crucially, a hot, red, swollen joint with fever or chills can be a joint infection (septic arthritis), which looks like gout but is an emergency.
This article is for general education only. It is not medical advice and contains no dosing guidance. Only a clinician can diagnose gout, distinguish it from a joint infection or other arthritis, and choose your medications. Seek urgent care for a hot, swollen joint with fever. Call 911 for any life-threatening emergency.
What Causes Gout?
Gout is caused by the deposition of monosodium urate (MSU) crystals in joints and surrounding tissues. These crystals form when blood levels of uric acid exceed the saturation point — approximately 6.8 mg/dL — and the dissolved urate begins to crystallize. According to NIAMS, hyperuricemia (elevated uric acid) is the necessary precondition for gout, though not everyone with hyperuricemia develops the disease. In fact, hyperuricemia is far more common than gout itself, which is why an elevated uric acid level alone — without symptoms — is generally not treated with medication.
Uric acid is the end product of purine metabolism. Purines come from two sources: the body’s own production (which accounts for roughly two-thirds of the uric acid pool) and dietary intake of purine-rich foods. The kidneys excrete most daily uric acid, with the remainder eliminated through the gut. In the majority of gout patients, the underlying problem is underexcretion of uric acid by the kidneys rather than overproduction.
Risk factors for gout include male sex (gout is several times more common in men than in premenopausal women), advancing age, obesity, chronic kidney disease, hypertension, diabetes, metabolic syndrome, and a family history of gout. Genetics play a large role in how the kidneys handle urate. Certain medications — particularly thiazide and loop diuretics, low-dose aspirin, and cyclosporine — raise uric acid levels. Diet contributes too: high intake of red meat, organ meats, shellfish, alcohol (especially beer and spirits), and sugar-sweetened beverages is associated with increased risk.
The Stages of Gout
Gout progresses through four clinical stages if left untreated. Understanding this natural history helps illustrate why long-term management matters.
Asymptomatic hyperuricemia — the first stage — involves elevated uric acid without any symptoms. Urate crystals may already be depositing silently. This stage can persist for years or a lifetime without progressing to clinical gout in some people, which is why it is usually monitored rather than medicated.
Acute gout flare — the second stage — is the dramatic event most people associate with the disease. A joint (classically the first metatarsophalangeal joint of the big toe, called podagra) becomes acutely inflamed over hours, with severe pain, redness, warmth, and swelling. The Mayo Clinic notes that flares often begin at night and peak within 12 to 24 hours. Other commonly affected joints include the ankle, knee, wrist, fingers, and elbow. Untreated flares typically resolve on their own within 7 to 14 days.
Intercritical gout — the period between flares — may feel like complete normality. However, MSU crystals persist in the joints even when symptoms are absent. Without urate-lowering therapy, flares tend to become more frequent, last longer, and involve more joints over time.
Chronic tophaceous gout — the most advanced stage — develops after years of inadequately treated hyperuricemia. Tophi (singular: tophus) are firm, white or yellowish deposits of urate crystals that form in and around joints, tendons, bursae, and even the pinnae of the ears. Tophi can cause joint destruction, deformity, and chronic pain. With effective modern treatment, this stage is largely preventable.
Red flag: a hot joint with fever could be septic arthritis. A single joint that is suddenly hot, red, and swollen together with fever, chills, or feeling generally unwell can be a joint infection (septic arthritis) — a medical emergency. Septic arthritis can look essentially identical to a gout flare from the outside; the two cannot be reliably told apart just by looking, and they can even occur at the same time. An infected joint can be destroyed within days without urgent treatment, which usually requires drawing fluid from the joint (aspiration) and antibiotics. If you have a hot, swollen joint with fever — especially if it is a new or unusually severe attack, or you have had recent skin infection, surgery, or a prosthetic joint — do not assume it is “just gout.” Seek urgent medical care or go to the ER.
Diagnosing Gout
The gold standard for gout diagnosis is identification of MSU crystals in synovial fluid aspirated from an affected joint. Under polarized light microscopy, MSU crystals appear as needle-shaped, negatively birefringent structures. This analysis is definitive and distinguishes gout from other causes of acute inflammatory arthritis — including pseudogout (calcium pyrophosphate deposition disease), which involves different crystals, and, critically, from a joint infection. Aspiration is the single best test when infection is a possibility, because fluid can be sent for culture at the same time.
In practice, joint aspiration is not always performed. The American College of Rheumatology acknowledges that a clinical diagnosis can be reasonably made when a patient presents with classic features: acute onset of monoarticular arthritis in a typical location (big toe, ankle, or knee), a history of hyperuricemia, rapid response to anti-inflammatory treatment, and resolution within 1 to 2 weeks. When the picture is atypical — or when fever raises concern for infection — aspiration becomes much more important.
Serum uric acid level is an important part of the evaluation but has limitations during an acute flare, when it may be falsely normal or even low. Levels should be rechecked a few weeks after a flare resolves for a more accurate baseline. Imaging can support the diagnosis: dual-energy CT (DECT) can detect urate deposits with high specificity, and ultrasound can reveal a “double contour sign” over the cartilage surface indicating urate deposition.
Managing an Acute Gout Flare
When a gout flare strikes, the priority is rapid pain relief and inflammation control, and treatment works best when started early — the American College of Rheumatology’s 2020 gout guideline emphasizes prompt initiation, ideally within the first day of a flare.
First-line options for acute flares fall into three classes: NSAIDs, colchicine, and corticosteroids (oral or injected). The choice among them depends on the patient’s other conditions, kidney function, and medication tolerances — for example, NSAIDs are often avoided in people with kidney disease, heart failure, or certain ulcers. Because the right agent and dose are so dependent on the individual, this article gives no dosing; those decisions belong with your clinician or pharmacist.
Intra-articular corticosteroid injection is an excellent option when a single large joint is involved — it provides rapid, targeted relief with minimal systemic effect (and is only used once infection has been excluded). Rest, ice, and elevation of the affected joint are helpful supportive measures. Importantly, if you are already taking urate-lowering therapy when a flare occurs, you should generally continue it — stopping it during a flare can worsen and prolong the episode by causing uric acid levels to swing.
For patients with frequent flares or those who cannot use first-line agents, the interleukin-1 (IL-1) inhibitor anakinra has evidence for acute flare management, and other IL-1 inhibitors are used in some settings. These are specialist options rather than routine first-line treatment.
Long-Term Urate-Lowering Therapy
The definitive treatment of gout is long-term urate-lowering therapy (ULT) to reduce serum uric acid below the saturation threshold, dissolve existing crystals, and prevent future flares and tophi. According to the ACR, ULT is strongly recommended for patients with frequent flares (generally two or more per year), tophi, radiographic joint damage from gout, or urate kidney stones. This is a treat-to-target strategy: the medication is adjusted until uric acid reaches and stays below a goal (commonly below 6 mg/dL, or lower for those with tophi), not simply prescribed at a fixed amount.
Allopurinol, a xanthine oxidase inhibitor, is the recommended first-line ULT. It is effective, inexpensive, and well tolerated for most patients. It is started low and titrated upward over weeks with periodic uric acid checks; your clinician manages this process, including extra caution in people with kidney disease and, in higher-risk groups, checking for a genetic marker (HLA-B*5801) linked to a rare severe skin reaction.
Febuxostat (Uloric) is an alternative xanthine oxidase inhibitor for patients who cannot tolerate allopurinol. It carries an FDA boxed warning regarding cardiovascular death based on the CARES trial, so it is generally reserved for those who have failed or cannot take allopurinol, and the decision weighs an individual’s cardiovascular risk. Probenecid, a uricosuric agent that increases renal uric acid excretion, is another option, particularly for underexcreters with preserved kidney function. For severe, refractory tophaceous gout that does not respond to oral agents, an intravenous medication called pegloticase can dramatically lower uric acid under specialist care.
A critical counseling point: starting ULT can temporarily increase flares as dissolving crystals trigger inflammation. Anti-inflammatory “flare prophylaxis” is recommended for the first several months when beginning ULT. This period is essential; without it, patients often blame the medication and stop it — exactly the wrong move. Lowering uric acid steadily and sticking with treatment is what ultimately ends the flares.
Diet and Lifestyle in Gout Management
Dietary modification is a component of gout management but is insufficient as the sole treatment for most patients. Even strict dietary adherence typically reduces serum uric acid by only about 1 mg/dL — meaningful, but usually not enough to reach target on its own. In current guidelines, diet is framed as a helpful adjunct, not a substitute for medication when ULT is indicated. Medications and lifestyle changes work best together.
Evidence-based dietary suggestions from the Mayo Clinic and ACR include limiting high-purine foods (organ meats, game meats, and certain seafood like sardines and anchovies), reducing alcohol (especially beer and spirits), avoiding sugar-sweetened beverages and high-fructose corn syrup (fructose raises uric acid), and favoring low-fat dairy and plenty of water. These are general risk-reduction measures, not a cure.
Weight loss in people with overweight or obesity can lower uric acid and reduce flare frequency. However, rapid weight loss, crash diets, or fasting should be avoided, as they can paradoxically trigger flares by transiently raising uric acid. A gradual approach is recommended. Adequate hydration supports renal uric acid excretion. Cherry consumption and cherry extract have shown modest effects in some studies, though evidence is not strong enough for a formal recommendation.
Managing comorbidities is also important, as gout frequently coexists with hypertension, cardiovascular disease, diabetes, and chronic kidney disease. When appropriate, medications that raise uric acid (such as thiazide diuretics) may be swapped for alternatives that are neutral or mildly urate-lowering (for example, losartan) — a change your prescriber makes, not something to do on your own. Understanding the costs of managing multiple chronic conditions helps with long-term planning.
Gout and Kidney Disease
The relationship between gout and kidney disease is bidirectional. Chronic kidney disease impairs uric acid excretion, leading to hyperuricemia and gout. Conversely, chronic hyperuricemia and urate crystal deposition can contribute to kidney damage, and uric acid kidney stones are considerably more common in gout patients than in the general population.
Managing gout in patients with chronic kidney disease requires careful drug selection and dose adjustment. Allopurinol can still be used but is started lower and titrated with monitoring; colchicine requires dose reduction; and some NSAIDs should be avoided due to kidney risk. The National Kidney Foundation supports managing gout in CKD collaboratively, often involving both a rheumatologist and a nephrologist.
Frequently Asked Questions
Is gout caused by eating too much rich food?
Diet contributes to gout risk but is not the sole cause. Gout results from hyperuricemia, which is largely driven by genetic factors affecting how your kidneys handle uric acid. Diet accounts for only a small share of the variation in serum uric acid across the population. High-purine foods, alcohol, and fructose can raise uric acid and trigger flares, but many gout patients have relatively healthy diets. The old image of gout as a “disease of kings” caused purely by overindulgence is an oversimplification.
How long does a gout flare last?
Without treatment, a typical flare lasts 7 to 14 days before resolving on its own. With prompt treatment started early, flare duration is often shortened to a few days. Some severe flares — particularly with long-standing untreated gout or multiple joints involved — can persist for weeks. The speed of starting treatment is the most important factor in how long a flare lasts. If a flare comes with fever, have it evaluated to rule out infection.
Can gout be cured?
Gout can be effectively controlled to the point of “functional cure”: if serum uric acid is kept below the target for a sustained period, existing crystals dissolve, tophi shrink, and flares eventually cease. This requires long-term (often lifelong) urate-lowering therapy, and complete crystal dissolution may take one to two years or more depending on crystal burden. If ULT is stopped, uric acid rises, crystals reform, and flares return — which is why most rheumatologists recommend indefinite treatment.
Why does gout often affect the big toe?
The big toe joint is affected in about half of first attacks and in the great majority of patients at some point. Several factors make it susceptible: it is cooler than the body’s core (urate crystallizes more readily at lower temperatures), it takes repetitive mechanical stress from walking, and it is a dependent joint where gravity favors urate deposition. That said, gout can affect any joint, and later in the disease, multiple joints are often involved at once.
Can I drink alcohol if I have gout?
Alcohol is a well-established gout trigger. Beer is the highest risk due to its purine content, and spirits also raise uric acid and flare risk. Wine appears to carry a lower association, though heavy intake is still problematic. If you have gout, limiting alcohol — or abstaining, particularly during flares or when starting ULT — is advisable. Discuss your specific situation with your doctor, as the right approach depends on your disease severity and overall health.
Taking Control of Your Gout
If you’ve had even one gout flare, you’re dealing with a condition that will likely recur without proactive management. The most important conversation to have with your doctor is about long-term urate-lowering therapy — not just treating the next flare when it happens. Ask what your serum uric acid level is and what target you should aim for, and remember that lifestyle changes support, but do not replace, prescribed medication when it is indicated.
Don’t be discouraged if starting ULT triggers additional flares in the short term. This is expected and manageable with anti-inflammatory prophylaxis, and it is not a reason to stop. It takes time — often months — for uric acid to reach target and for crystals to dissolve. Persistence pays off: patients who maintain target uric acid experience fewer and eventually zero flares.
Combine medication with sensible lifestyle changes: maintain a healthy weight, stay well hydrated, limit high-purine foods and alcohol, and manage your other conditions (hypertension, kidney disease, diabetes). And keep the one safety rule front of mind — a hot, swollen joint with fever deserves urgent evaluation to rule out infection, not a wait-and-see approach. Gout is among the most controllable chronic diseases in medicine, but only if you and your healthcare team commit to a long-term strategy rather than a cycle of reactive flare management.
Sources
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) — gout causes, symptoms, and treatment
- American College of Rheumatology — 2020 guideline for the management of gout (urate-lowering therapy, treat-to-target, flare management)
- Mayo Clinic — gout symptoms, diagnosis, diet, and treatment
- MedlinePlus — patient overview of gout and septic arthritis
- National Kidney Foundation — gout and chronic kidney disease
- FDA / DailyMed — febuxostat (Uloric) prescribing information, including the cardiovascular boxed warning